Harrow has introduced Vevye Access for All, an initiative that guarantees access to Vevye (cyclosporine ophthalmic solution) 0.1% for eligible patients and health plans for $59, ensuring that every patient can affordably start treatment without delay, the company said in a press release.

The program is now available through Harrow’s PhilRx mail-order pharmacy partner. According to Harrow, key benefits include:

• No prior authorization submission delays for eligible patients: Physicians can prescribe Vevye without prior authorization paperwork, step edits, and other treatment obstacles.
• No-delay prescription processing: PhilRx, a Harrow national mail-order pharmacy partner, expedites prescription fulfillment with free home delivery, ensuring patients receive their medication promptly and conveniently.
• Lower patient costs: Eligible patients can receive their first prescription for as little as $0¹; and refills are available at $59 per bottle for eligible patients, with further discounts available for 3-bottle orders.
• Money-back guarantee: Harrow provides a no‑questions‑asked money-back guarantee.²

“For too long, patients, doctors, and pharmaceutical companies have been at the mercy of unseen middlemen who act as access gatekeepers, using needless red tape to prevent patients from benefitting from medications they are prescribed,” said Mark L. Baum, chief executive officer of Harrow, in the press release. “These tactics are a horribly unfair financial and logistical burden on eyecare professionals, and patients are often left to pay higher out‑of‑pocket co-payments for drugs that may not even be what their doctor prescribed. [Vevye Access for All] puts power back where it belongs—in the hands of eyecare professionals and their patients—by simplifying the prescribing and dispensing process and removing access impediments for all patients, creating a more frictionless path to therapy.”

The company plans to make the program widely available through all pharmacy networks.

1. For patients whose prescriptions are covered by commercial insurance, use of this program may reduce their Vevye copayment to as little as $0. For patients whose prescriptions are not covered by commercial insurance, this program may reduce their cost for prescriptions to as little as $59. For full terms and conditions, please visit vevye.com/accessforall.

2. This offer is available on one fill only and is valid only for eligible patients paying cash who do not have commercial or government insurance. This offer is not valid for patients with government insurance, including, but not limited to, Medicaid or Medicare. Contact Harrow at 833-443-7769 for information on our money-back guarantee.